102 related articles for article (PubMed ID: 16540155)
1. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
Markman M
Gynecol Oncol; 2006 Jun; 101(3):550-1; author reply 551-2. PubMed ID: 16540155
[No Abstract] [Full Text] [Related]
2. Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes.
Bristow RE; Giuntoli RL; Pannu HK; Schulick RD; Fishman EK; Wahl RL
Gynecol Oncol; 2005 Nov; 99(2):294-300. PubMed ID: 16051330
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrent ovarian cancer at MRI: comparison with integrated PET/CT.
Kim CK; Park BK; Choi JY; Kim BG; Han H
J Comput Assist Tomogr; 2007; 31(6):868-75. PubMed ID: 18043348
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review.
Makhija S; Howden N; Edwards R; Kelley J; Townsend DW; Meltzer CC
Gynecol Oncol; 2002 Apr; 85(1):53-8. PubMed ID: 11925120
[TBL] [Abstract][Full Text] [Related]
5. Combined FDG-positron emission tomography and computed tomography for the detection of ovarian cancer recurrence in an inguinal hernia sac.
Díaz-Montes TP; Jacene HA; Wahl RL; Bristow RE
Gynecol Oncol; 2005 Sep; 98(3):510-2. PubMed ID: 15992914
[TBL] [Abstract][Full Text] [Related]
6. The impact of PET-CT in suspected recurrent ovarian cancer: a prospective multi-centre study as part of the Australian PET Data Collection Project.
Markman M
Gynecol Oncol; 2009 Sep; 114(3):536; author reply 536-7. PubMed ID: 19482342
[No Abstract] [Full Text] [Related]
7. Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer.
Barranger E; Kerrou K; Petegnief Y; David-Montefiore E; Cortez A; Daraï E
Gynecol Oncol; 2005 Jan; 96(1):241-4. PubMed ID: 15589609
[TBL] [Abstract][Full Text] [Related]
8. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent ovarian carcinoma. Initial report.
Yuan CC; Liu RS; Wang PH; Ng HT; Yeh SH
J Reprod Med; 1999 Sep; 44(9):775-8. PubMed ID: 10509300
[TBL] [Abstract][Full Text] [Related]
9. Combined positron emission tomography-computed tomography and tumor markers for detecting recurrent ovarian cancer.
Pan HS; Lee SL; Huang LW; Chen YK
Arch Gynecol Obstet; 2011 Feb; 283(2):335-41. PubMed ID: 20221620
[TBL] [Abstract][Full Text] [Related]
10. The impact of PET/CT in the management of recurrent ovarian cancer.
Simcock B; Neesham D; Quinn M; Drummond E; Milner A; Hicks RJ
Gynecol Oncol; 2006 Oct; 103(1):271-6. PubMed ID: 16626793
[TBL] [Abstract][Full Text] [Related]
11. Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancer.
Thrall MM; DeLoia JA; Gallion H; Avril N
Gynecol Oncol; 2007 Apr; 105(1):17-22. PubMed ID: 17208284
[TBL] [Abstract][Full Text] [Related]
12. [Role of positron emission tomography in diagnosis of recurrent ovarian cancer].
Ding XL; Shen K; Lang JH; Wu M; Huang HF; Pan LY; Yang JX
Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):667-9. PubMed ID: 14728852
[TBL] [Abstract][Full Text] [Related]
13. [Value of positron emission tomography-CT imaging combined with continual detection of CA125 in serum for diagnosis of early asymptomatic recurrence of epithelial ovarian carcinoma].
Sheng XG; Zhang XL; Fu Z; Li HQ; Li QS; Ma ZF; Li DP; Chen ZY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):460-3. PubMed ID: 17961335
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer.
Cho SM; Ha HK; Byun JY; Lee JM; Kim CJ; Nam-Koong SE; Lee JM
AJR Am J Roentgenol; 2002 Aug; 179(2):391-5. PubMed ID: 12130439
[TBL] [Abstract][Full Text] [Related]
15. FDG-PET for management of cervical and ovarian cancer.
Havrilesky LJ; Kulasingam SL; Matchar DB; Myers ER
Gynecol Oncol; 2005 Apr; 97(1):183-91. PubMed ID: 15790456
[TBL] [Abstract][Full Text] [Related]
16. [The accuracy of CT and tumor markers in the detection of a recurrent ovarian carcinoma].
Wakabayashi Y; Ishida J; Kotake F; Hirose M; Kawana K; Abe K; Amino S; Negishi Y; Akiya K
Gan No Rinsho; 1989 Sep; 35(10):1127-31. PubMed ID: 2550684
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of integrated whole-body PET/CT in the detection of recurrent ovarian cancer.
Hauth EA; Antoch G; Stattaus J; Kuehl H; Veit P; Bockisch A; Kimmig R; Forsting M
Eur J Radiol; 2005 Nov; 56(2):263-8. PubMed ID: 16233894
[TBL] [Abstract][Full Text] [Related]
18. (18)F-FDG PET/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients.
Nanni C; Rubello D; Farsad M; De Iaco P; Sansovini M; Erba P; Rampin L; Mariani G; Fanti S
Eur J Surg Oncol; 2005 Sep; 31(7):792-7. PubMed ID: 15893908
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of positron emission tomography/computed tomography in the diagnosis and restaging for recurrent ovarian cancer: a meta-analysis.
Limei Z; Yong C; Yan X; Shuai T; Jiangyan X; Zhiqing L
Int J Gynecol Cancer; 2013 May; 23(4):598-607. PubMed ID: 23502451
[TBL] [Abstract][Full Text] [Related]
20. Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose.
Torizuka T; Nobezawa S; Kanno T; Futatsubashi M; Yoshikawa E; Okada H; Takekuma M; Maeda M; Ouchi Y
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):797-803. PubMed ID: 12029554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
